Literature DB >> 19818455

A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.

Shirley W Tsang1, Janet Keene, Tony Hope, Ian Spence, Paul T Francis, Peter T-H Wong, Christopher P Chen, Mitchell K Lai.   

Abstract

Hyperphagia and associated eating changes occur frequently in Alzheimer's disease (AD) and lead to considerable morbidity. However, the neurochemical basis for these neuropsychiatric behaviours is at present unclear. In this study, we measured serotonin transporters, 5-HT(1A), 5-HT(2A), and 5-HT(4) receptors using radioligand binding assays in the postmortem temporal cortex of a cohort of controls and AD patients longitudinally assessed for hyperphagia. We found significant decreases in 5-HT(4) receptor densities in the hyperphagic, but not normophagic, AD group. Our data suggest that 5-HT(4) receptor deficits may be a specific neurochemical correlate of hyperphagia, and point to the potential pharmacotherapeutic utility of 5-HT(4) agonists for these behaviours in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818455     DOI: 10.1016/j.jns.2009.08.066

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

Authors:  Mitchell K P Lai; Shirley W Tsang; Margaret M Esiri; Paul T Francis; Peter T-H Wong; Christopher P Chen
Journal:  Psychopharmacology (Berl)       Date:  2010-07-13       Impact factor: 4.530

Review 2.  The role of serotonin in respiratory function and dysfunction.

Authors:  Gérard Hilaire; Nicolas Voituron; Clément Menuet; Ronaldo M Ichiyama; Hari H Subramanian; Mathias Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2010-08-27       Impact factor: 1.931

Review 3.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

4.  5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

Authors:  Maud Cochet; Romain Donneger; Elisabeth Cassier; Florence Gaven; Stefan F Lichtenthaler; Philippe Marin; Joël Bockaert; Aline Dumuis; Sylvie Claeysen
Journal:  ACS Chem Neurosci       Date:  2012-10-13       Impact factor: 4.418

5.  Metabolic changes over the course of aging in a mouse model of tau deposition.

Authors:  Aurélie Joly-Amado; Karisa S Serraneau; Milene Brownlow; Caralina Marín de Evsikova; John R Speakman; Marcia N Gordon; Dave Morgan
Journal:  Neurobiol Aging       Date:  2016-04-25       Impact factor: 4.673

6.  Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model.

Authors:  Adedolapo Adebakin; Jenna Bradley; Sarah Gümüsgöz; Elizabeth J Waters; Catherine B Lawrence
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

Review 7.  The serotonergic system and cognitive function.

Authors:  Dubravka Švob Štrac; Nela Pivac; Dorotea Mück-Šeler
Journal:  Transl Neurosci       Date:  2016-05-09       Impact factor: 1.757

Review 8.  Alterations of Expression of the Serotonin 5-HT4 Receptor in Brain Disorders.

Authors:  Heike Rebholz; Eitan Friedman; Julia Castello
Journal:  Int J Mol Sci       Date:  2018-11-13       Impact factor: 5.923

9.  Protective Effects of 5-HT1A Receptor Inhibition and 5-HT2A Receptor Stimulation Against Streptozotocin-Induced Apoptosis in the Hippocampus.

Authors:  Siamak Shahidi; Nasrin Hashemi-Firouzi; Simin Afshar; Sara Soleimani Asl; Alireza Komaki
Journal:  Malays J Med Sci       Date:  2019-04-30

Review 10.  Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT.

Authors:  Lieven D Declercq; Rik Vandenberghe; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.